1054636-37-1 = 83465-22-9 反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Methanol,Water; 24 H,Rt 标题:Improved Stereoselective Syntheses Of (+)-Valiolamine And (+)-Valienamine Starting From (-)-Shikimic Acid 作者:Li,Fenglei; Et Al 参考文献:Chinese Journal Of Chemistry 日期:2017 卷标:35(4) 页码:457-464]
118014-37-2 = 83465-22-9 反应条件:1.1 Reagents: Barium Hydroxide Solvents: Water; 8 H,80 °C; 80 °C -> Rt1.2 Reagents: Carbon Dioxide; Rt1.3 Reagents: Amberlite Cg 50 Solvents: Water; 5 H,Rt1.4 Reagents: Dowex 50W Solvents: Water; 2 H,Rt 标题:Diastereospecific Epoxidation And Highly Regioselective Ring-Opening Of (+)-Valienamine: Practical Synthesis Of (+)-Valiolamine 作者:Ji,Li; Et Al 参考文献:Tetrahedron 日期:2013 卷标:69(34) 页码:7031-7037]
= 83465-22-9 反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Water; 3 H,80 °C 标题:Convenient Synthesis Of (+)-Valiolamine And (-)-1-Epi-Valiolamine From (-)-Vibo-Quercitol 作者:Ogawa,Seiichiro; Et Al 参考文献:Organic & Biomolecular Chemistry 日期:2004 卷标:2(6) 页码:884-889]
= 83465-22-9 反应条件:1.1 Reagents: Lithium,Ammonia Solvents: Tetrahydrofuran; -78 °C; 3 H,-60 °C1.2 Reagents: Water; -60 °C; -60 °C -> Rt1.3 Reagents: Lithium Hydroxide Solvents: Ethanol,Water; Rt; 1 H,80 °C1.4 Reagents: Acetic Acid Solvents: Water; 18 H,50 °C 标题:A C2-Symmetric Pool Based Flexible Strategy: An Enantio-Convergent Synthesis Of (+)-Valiolamine And (+)-Valienamine 作者:Lo,Hong-Jay; Et Al 参考文献:European Journal Of Organic Chemistry 日期:2012 卷标:2012(14) 页码:2780-2785]
= 83465-22-9 反应条件:1.1 Reagents: Barium Hydroxide Solvents: Water 标题:Stereoselective Conversion Of Valienamine And Validamine Into Valiolamine 作者:Horii,Satoshi; Et Al 参考文献:Carbohydrate Research 日期:1985 卷标:140(2) 页码:185-200]
1054636-37-1 = 83465-22-9 反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Methanol,Water; 24 H,Rt 标题:Total Syntheses Of (+)-Valiolamine And (-)-1-Epi-Valiolamine From Naturally Abundant (-)-Shikimic Acid 作者:Quan,Na; Et Al 参考文献:European Journal Of Organic Chemistry 日期:2013 卷标:2013(28) 页码:6389-6396]
1060713-64-5 = 83465-22-9 反应条件:1.1 Reagents: Trifluoroacetic Acid Solvents: Dichloromethane; 2 D,Rt 标题:Intramolecular Direct Aldol Reactions Of Sugar Diketones: Syntheses Of Valiolamine And Validoxylamine G 作者:Shing,Tony K. M.; Et Al 参考文献:Organic Letters 日期:2008 卷标:10(18) 页码:4137-4139]
85281-06-7 = 83465-22-9 反应条件:1.1 Reagents: Barium Hydroxide Solvents: Water 标题:Stereoselective Conversion Of Valienamine And Validamine Into Valiolamine 作者:Horii,Satoshi; Et Al 参考文献:Carbohydrate Research 日期:1985 卷标:140(2) 页码:185-200]
= 83465-22-9 反应条件:1.1 Reagents: Potassium Carbonate Solvents: Methanol1.2 Reagents: Hydrogen Catalysts: Palladium Dihydroxide Solvents: Ethanol 标题:Enantiospecific Syntheses Of Valiolamine And Its (1R),(2R),(1R,2R) Diastereomers From (-)-Quinic Acid 作者:Shing,Tony K. M.; Et Al 参考文献:Angewandte Chemie 日期:1995 卷标:34(15) 页码:1643-5]
= 83465-22-9 [标题:Reaction Conditions 标题:Inosose Derivatives As Intermediates For Valienamine And Valiolamine And A Process For Their Preparation 参考文献:European Patent Organization]
115250-38-9 = 83465-22-9 [标题:Reaction Conditions 标题:Inosose Derivatives As Intermediates For Valienamine And Valiolamine And A Process For Their Preparation 参考文献:European Patent Organization]
= 83465-22-9 反应条件:1.1 Reagents: Barium Hydroxide Solvents: Water 标题:Stereoselective Conversion Of Valienamine And Validamine Into Valiolamine 作者:Horii,Satoshi; Et Al 参考文献:Carbohydrate Research 日期:1985 卷标:140(2) 页码:185-200
Tetra-O-Benzylvaliolamine置于palladium 10% On Activated Carbon 盐酸,氢气体系中,用 四氢呋喃,甲醇,水 作为反应溶剂,40.0 °C,294.2 Kpa 条件下,反应 4.5H,反应生成 井冈霉醇胺 参考文献: Process For The Preparation Of 1,2,3,4-Cyclohexanetetrol Derivatives[fr] Procede Pour La Preparation De Derives De 1,2,3,4-Cyclohexanetetrol 标题: Process For The Preparation Of 1,2,3,4-Cyclohexanetetrol Derivatives[fr] Procede Pour La Preparation De Derives De 1,2,3,4-Cyclohexanetetrol 摘要:本文提供了制备1,2,3,4-环己烷四醇衍生物的方法,这些衍生物是合成沃格利波糖的有用中间体;制备取代的2,3,4,5-四羟基环己酮的方法;以及制备沃格利波糖的方法.还提供了通过这些方法形成的化合物.
专利号:WO-2005049547-A1 优先权日:2003-11-21 标 题 :Process for the preparation of 1,2,3,4-cyclohexanetetrol derivatives 发明人:KHANDURI CHANDRA HAS; BABU JAYACHANDRA SURESH; RAY PURNA CHANDRA; SHAH JIGAR BHASKARBHAI; KUMAR YATENDRA 权利人:RANBAXY LAB LTD; KHANDURI CHANDRA HAS; BABU JAYACHANDRA SURESH; RAY PURNA CHANDRA; SHAH JIGAR BHASKARBHAI; KUMAR YATENDRA 摘要:Provided herein are processes for the preparation of 1,2,3,4-cyclohexanetetrol derivatives, which are useful intermediates for the synthesis of voglibose; processes for the preparation of substituted 2,3,4,5-tetrahydroxycyclohexanone; and processes for preparing voglibose. Also provided are compounds formed by such processes.
专利号:US-2007032537-A1 优先权日:2003-06-13 标题:5-Substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the acid receptor rup25 for the treatment of dyslipidemia and related diseases 发明人:SEMPLE GRAEME; GHARBAOUI TAWFIK; SHIN YOUNG-JUN; DECAIRE MARC; AVERBUJ CLAUDIA L; SKINNER PHILIP J 权利人:ARENA PHARM INC 摘要:The present invention relates to certain pyrazole carboxylic acid and ester derivatives, and pharmaceutically acceptable salts thereof, which exhibit useful pharmaceutical properties, for example as agonists for the RUP25 receptor. (I) Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the prophylaxis or treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like. In addition, the present invention also provides for the use of the compounds of the invention in combination with other active agents such as those belonging to the class of α-glucosidase inhibitors, aldose reductase inhibitors, biguanides, HMG-CoA reductase inhibitors, squalene synthesis inhibitors, fibrates, LDL catabolism enhancers, angiotensin converting enzyme (ACE) inhibitors, insulin secretion enhancers and the like the substituents are defined in claim 1.
专利号:WO-2006127595-A1 优先权日:2005-05-23 标题:5-aminopyrazole carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereof 发明人:SKINNER PHILIP J; SEMPLE GRAEME; WEBB PETER 权利人:ARENA PHARM INC; SKINNER PHILIP J; SEMPLE GRAEME; WEBB PETER 摘要:The present invention relates to certain pyrazole carboxylic acid or ester derivatives of Formula (I) and pharmaceutically acceptable salts thereof which exhibit useful pharmacological properties, for example, as agonists for the GPCR referred to herein as RUP38. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, such as, dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like. In addition, the present invention also provides for the use of the compounds of the invention in combination with other active agents such as those belonging to the class of -glucosidase inhibitors, aldose reductase inhibitors, biguanides, HMG-CoA reductase inhibitors, squalene synthesis inhibitors, fibrates, LDL catabolism enhancers, angiotensin converting enzyme (ACE) inhibitors, insulin secretion enhancers and the like.
专利号:US-6538131-B1 优先权日:1999-04-19 标 题 :Synthetic process for highly functionalized carbocyclic polyols and substituted sugar analogs 发明人:AL-ABED YOUSEF; SEEPERSAUD MOHINDRA 权利人:PICOWER INST MED RES 摘要:Chemical processes for more efficient synthesis of carbocyclic polyols and substituted sugar analogs are disclosed, together with a novel class of cyclopentene polyol intermediate products and anhydro derivatives thereof.
专利号:CN-102105455-A 优先权日:2008-08-08 标题 :Stereoselective synthesis of valiolamine
专利号:WO-2010015107-A1 优先权日:2008-08-08 标题:Stereoselective synthesis of valiolamine
1: Karade SS, Hill ML, Kiappes JL, Manne R, Aakula B, Zitzmann N, Warfield KL, Treston AM, Mariuzza RA. N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity. J Med Chem. 2021 Dec 23;64(24):18010-18024. doi: 10.1021/acs.jmedchem.1c01377. Epub 2021 Dec 6. 15(7):12188-95. doi: 10.3390/ijms150712188. 3: Bin BH, Seo J, Yang SH, Lee E, Choi H, Kim KH, Cho EG, Lee TR. Novel inhibitory effect of the antidiabetic drug voglibose on melanogenesis. Exp Dermatol. 2013 Aug;22(8):541-6. doi: 10.1111/exd.12195. 81(4-5):1613-8. doi: 10.1016/j.talanta.2010.03.011. Epub 2010 Mar 19. 49(4):957-63. doi: 10.1016/j.jpba.2009.02.020. Epub 2009 Feb 27. 9(1):58-75. doi: 10.2174/156802609787354324. 10(18):4137-9. doi: 10.1021/ol801889n. Epub 2008 Aug 26. 70(3):493-7. doi: 10.1021/np068069t. Epub 2007 Mar 9. 1(1):12. doi: 10.1186/1860-5397-1-12. 10: Chen X, Zheng Y, Shen Y. Voglibose (Basen, AO-128), one of the most important alpha-glucosidase inhibitors. Curr Med Chem. 2006;13(1):109-16. doi: 10.2174/092986706789803035. 2(6):884-9. doi: 10.1039/b314795a. Epub 2004 Feb 18. 338(20):2075-82. doi: 10.1016/s0008-6215(03)00315-x. 123(12):2733-42. doi: 10.1021/ja003643n. 2(4):457-60. doi: 10.1021/ol9913035. 59(2 Suppl):74-8. Spanish. 38(7):1970-2. doi: 10.1248/cpb.38.1970. 108(1):42-6. doi: 10.1093/oxfordjournals.jbchem.a123160. 29(6):1038-46. doi: 10.1021/jm00156a023. 38(12):1816-8. doi: 10.7164/antibiotics.38.1816. 37(11):1301-7. doi: 10.7164/antibiotics.37.1301.